346.50 USD
▼-7.33-2.07%
盘后 343.87 -0.76%
2026-09-15
市值
$39.40B
市盈率
61.99
EPS
5.59
股息率
—
52 周区间
253.95 – 385.22
成交量
257.30K
Beta
0.52
目标价
432.80
52W 低 253.9552W 高 385.22
价格走势
公司简介
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients w...
关联新闻
- Trump Administration Reaches Drug Pricing Deals With 9 Companies
The agreements provide for all state Medicaid programs to pay prices for prescription drugs that match the lowest prices paid by other developed nations, the White House said